Uncontrolled Postviral Asthma and Persistent Symptoms After COVID-19 (COVID-19)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05919004 |
Recruitment Status :
Completed
First Posted : June 26, 2023
Last Update Posted : June 28, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Long COVID | Diagnostic Test: App-based spirometer |
Study Type : | Observational |
Actual Enrollment : | 30 participants |
Observational Model: | Other |
Time Perspective: | Retrospective |
Official Title: | Uncontrolled Postviral Asthma in Patients With Long Covid |
Actual Study Start Date : | May 1, 2022 |
Actual Primary Completion Date : | November 1, 2022 |
Actual Study Completion Date : | December 31, 2022 |
- Diagnostic Test: App-based spirometer
App-based spirometer to perform serial spirometry to assess lung function variatione
- Excessive lung function variation [ Time Frame: 8 months ]Lung function given as FEV1.
- Perceived symptoms of long covid [ Time Frame: 8 months ]On a Likert scale 1-10
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 70 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Sampling Method: | Probability Sample |
Inclusion Criteria:
° Patients with long covid for more than 6 months referred for physical rehabilitation
Exclusion Criteria:
° None
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05919004
Norway | |
Idrettens Helsesenter | |
Oslo, Norway |
Responsible Party: | Tonje Reier-Nilsen, MD PhD, The Norwegian Sports Medicine Centre - Football Association, Oslo, Norway |
ClinicalTrials.gov Identifier: | NCT05919004 |
Other Study ID Numbers: |
IdrettensHelsesenter |
First Posted: | June 26, 2023 Key Record Dates |
Last Update Posted: | June 28, 2023 |
Last Verified: | June 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
postviral asthma diagnosis long covid |
telemedicine lung function digital spirometer |
Post-Acute COVID-19 Syndrome Respiratory Tract Diseases Lung Diseases COVID-19 Pneumonia, Viral Pneumonia Respiratory Tract Infections Infections Virus Diseases |
Coronavirus Infections Coronaviridae Infections Nidovirales Infections RNA Virus Infections Post-Infectious Disorders Chronic Disease Disease Attributes Pathologic Processes |